Tetra Bio Pharma Inc. (TBPMF) Granted Two OTC Drug Identification Numbers (DIN) by Health Canada

Tetra Bio-Pharma Granted Two OTC Drug Identification Numbers (DIN) by Health Canada…

Tetra Bio-Pharma Inc. (TBPMF) Receives Favorable Letter of Advice from USA FDA for QIXLEEF

Tetra Bio-Pharma Receives Favorable Letter of Advice from USA FDA for QIXLEEF…

 Tetra Bio-Pharma Inc. (TBPMF) Provides Update on its Hepatocellular Carcinoma Drug HCC011

Tetra Bio-Pharma Provides Update on its Hepatocellular Carcinoma Drug HCC011  Tetra Bio-Pharma…

Tetra Bio-Pharma Inc. (TBPMF) Receives FDA Orphan Drug Designation for Hepatocellular Carcinoma

Tetra Bio-Pharma Receives FDA Orphan Drug Designation for Hepatocellular Carcinoma Tetra Bio-Pharma…

 Tetra Bio-Pharma Inc. (TBPMF) Pharma Signs Definitive Commercialization Agreement for CAUMZ(TM)

Tetra Bio-Pharma Signs Definitive Commercialization Agreement for CAUMZ(TM) in Mexico With Alternavida…

Tetra Bio-Pharma Inc. (TBPMF) Announces Approval to List on the TSX Venture Exchange

Tetra Bio-Pharma Announces Approval to List on the TSX Venture Exchange Tetra…

Tetra Bio-Pharma (TBPMF) (CSE:TBP) Appoints Aphria CFO to the Board of Directors

OTTAWA, ONTARIO–(Marketwired – Jun 14, 2017) – Tetra Bio-Pharma Inc. (“Tetra” or…